Dr. List discusses results from the MEDALIST trial in patients with transfusion-dependent myelodysplastic syndromes, which were presented as a plenary abstract at the 2018 ASH Annual Meeting.
Негізгі бет Alan List: Is Luspatercept a New Option for Patients With MDS?
No video
Пікірлер: 2